Improving Regulatory Transparency for New Medical Therapies Act
United States Congress · 2015
Read Improving Regulatory Transparency for New Medical Therapies Act by United States Congress (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plaw-114-89-2015.txt.
Description
Improving Regulatory Transparency for New Medical Therapies Act is Public Law 114-89, passed in 2015 by the 114th Congress. The act amends the Controlled Substances Act on drug timing advice and on sign-up for makers who run trials. For a new drug the health chief plans to judge and urge controls on, grant of the drug request does not take effect till a first controlling rule is issued. The grant date is the later of the grant date or the rule date.
Catalog record
| CREATOR | United States Congress |
|---|---|
| YEAR | 2015 |
| COLLECTION | DECLASSIFIED |
| FORMAT | TXT |
| FILE SIZE | 14754 |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Government Publishing Office (govinfo.gov) |